Dist-Jalgaon, India

Prabhakar Salunkhe

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prabhakar Salunkhe: Innovator in Anticancer Research

Introduction

Prabhakar Salunkhe is a notable inventor based in Dist-Jalgaon, India. He has made significant contributions to the field of cancer research through his innovative work on anticancer agents. His dedication to developing effective treatments for cancer has positioned him as a key figure in the pharmaceutical industry.

Latest Patents

Salunkhe holds a patent for an anticancer agent that provides microbial products as therapeutic solutions. This invention includes pharmaceutical compositions comprising isolated and purified proteins or synthetic peptides. The methods outlined in his patent focus on using these compounds for the treatment of cancer. His work emphasizes the importance of creating new anticancer bioactive peptides that exhibit high activity and low toxicity, addressing the limitations of existing therapies.

Career Highlights

Throughout his career, Prabhakar Salunkhe has been associated with Amrita Therapeutics Limited, where he has contributed to groundbreaking research in the field of oncology. His innovative approach and commitment to finding effective cancer treatments have garnered attention and respect within the scientific community.

Collaborations

Salunkhe has worked alongside talented colleagues, including Anil Suri and Deepika Kanojia. Their collaborative efforts have further advanced the research and development of novel anticancer therapies.

Conclusion

Prabhakar Salunkhe's contributions to cancer research through his patented anticancer agent highlight his commitment to improving treatment options for patients. His work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…